Penicillin - Combinations
-
Ampicillin/Sulbactam
(Unasyn)
-
Ticarcillin/Clavulanic Acid
(Timentin)
-
Piperacillin/Tazobactam
(Zosyn)
- IV 3.375 gram q6h
-
Good for Pseudomonas auruginosa and Proteus mirabilis
- 4.5 grams for P. auruginosa
-
Amoxicillin/Clavulanic Acid
(Augmentin)
Tetracyclines
- CA MRSA
-
Adverse Effects:
- Photosensitivity
- Doxycycline – photo-onycholysis
-
CI:
- Pregnancy/Children – Permanent tooth discoloration
- Antacids, milk, food, &/or iron limits absorption
- May cause acute pancreatitis
-
Drugs
- Tetracycline HCL (Short)
- Methacycline (Intermediate)
-
Doxycycline
(long)
- Erosive esophagitis risk when taken before bedtime
- May reduce progression of OA as a MMP inhibitor (anti-inflammatory property)
- Minocycline
-
Tigacycline (Tygacil)
- HA MRSA & VRE
- Permanent discoloration of teeth during developmet
- IV only; 100 mg initial dose, 50 mg q12h
Lincosamide – Clindamycin (Cleocin)
- CA MRSA
- Fulminant Strep A (necrotizing fasciitis)
- Staphylococcus aureus resistant to erythromycin on C&S can develop inducible resistance to clindamycin
-
Adverse effects:
- Diarrhea
- Pseudomembranous colitis
- Preoperatve prophylaxis: 600-900mg 1 hr before surgery
- Good bone penetration/poor CNS penetration
Cephalosporins
-
1st generation
– “PEcK”
- Cephalexin, Cephadroxil, Cefazolin (Ancef)
-
Keflex (Cephalexin) 500mg
- #30 Tabs, T PO TID, 10 Days
-
2nd generation
– “HEN PEcKS”
-
3rd generation
- Cefixime, Cefpodoxime, Ceftriaxone (Rocephin), Ceftazidime, Cefdinir (Omnicef), Fortaz
- Fortaz: Pseudomonas
- Omnicef: Staph and Strep
- 4th generation: Cefipime (Maxipime)
- Extendend Spectrum: Ceftobiprole – HA MRSA
- Cefdinir and Cefuroxime – no PCN allergy
Carbepenams
- Contra-indicated: PCN allergy
- Primaxin (Imipenem/cilastin) – CI: Seizure
- Merrem (Meropenem) – less likely to cause seizures
- Invanz (Ertapenem) – 1 g q24h (CrCl <30 ml/min: 500 mg q24h; ≥6 hrs prior to hemodialysis) – CI: Seizure – DI: Probenecid
- Doripenem – phase II trials; P aeruginosa
Monobactams: Aztreonam (azactam)
- May be given to PCN allergy; no renal toxicity (can be given to may patients on dialysis)
Aminoglycosides: Tobramycin, Amikacin, Gentamycin (“TAG”)
- CA MRSA; Peak and Trough recommended; AE: ototoxicity (irreversible), Nephrotoxicity (reversible), Hypokalemia, Hypomagnesia
- Do Not use with diabetics or Myasthenia gravis
Vancomycin (glycopeptide):
- 1gram q12 IV (>70 kg) NRDA
- HA MRSA; Oral – Clostridium difficile associated psedomembranous colitis
- Endocartditis prophylaxis for pts allergic to B-Lactams and for “going into infected tissue”
- AE: ototoxicity (reversible), Nephrotoxicity (reversibile), thrombophlebitis, Red man syndrome (histamine release)
Macrolides: Azithromycin, Clarithromycin, Erythromycin (“ACE”)
- Major DI: digoxin (↑), HMG CoA reductase inhibitors (↑), Coumadin (↑)
- Erythromycin – Torsades de pointes – inhibitor of CYP3A4
- Azithromycin (zithromax) – 500 mg 1st day, 250 mg qd x 4 days
Sulfonamides: Sulfamethoxazole-trimethoprim sulfate (Bactrim or Septra)
- CA MRSA
- Caution: age >50; Extreme: oral sulfonylureas (risk hypoglycemia)
- Enhance marrow suppression in pts on Methotrexate
- Acute pancreatitis
Metronidazole (flagyl):
- Pseudomembranous colitis
- AE: peripheral neuropathy, dark brown urine
- 15 mg/kg then 7.5 mg/kg q6h IV; 500 mg tid PO
Fluoroquinolones: -floxacin
- false positive opiate test
- Torsades de pointes & ventricular fibrillation
- DI: Antacids, Phenytoin
-
Ciprofloxacin
- CI: pregnancy/children – damage joint cartilage
- Tendonitis and tendon rupture
- DI: caffeine, NSAIDs
- 750 mg po q12h (IV=PO for bone penetration – treat OM)
-
Levofloxacin (levaquin)
- CI: pregnancy/children – damage joint cartilage
- Post-antibiotic effect
- Excellent tissue penetration
- Uncomplicated skin and soft tissue infection
- 500 mg q24h po or IV
-
Moxifloxacin (avelox)
- Complicated and Uncomplicated skin and Soft tissue infections
- B. fragilis, Tuberculosis
- Good soft tissue penetration –good for diabetics w/atherosclerosis
Chloramphenicol:
- May be last resort for VRE
- AE: gray baby syndrome, severe bone marrow toxicity, aplastic anemia
- 50-100 mg/kg/day IV div q6h RDA
Rifamycin – Rifampin
- CA MRSA – with Bactrim or cipro (300 mg po bid)
- Orange body fluids – discolors contact lenses
Streptogramins – Synercid
- VRE, HA MRSA
- Cytochrome P450 3A4
Oxazolidinones – Zyvox (linezolid)
- VRE, MRSA, VRSE
- Good oral absorption and bone penetration
- Monitor CBCs weekly – myelosupression, peripheral/optic neruopathy
- Coadminister SSRIs and other antidepressants with caution
Cyclic Lipopeptide – Cubicin (Daptomycin)
- Monitor CPK weekly – especially pts on statins (potentiate myopathy)
- 4mg/kg q24h – QD for MRSA and VRSA
Glycylcyclines – Tygacil (tigecycline)
- HA MRSA & VRE
- Permanent discoloration of teeth development
- IV only; 100 mg initial dose, 50 mg q12h